193 related articles for article (PubMed ID: 27119637)
1. The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.
Sabareesan AT; Singh J; Roy S; Udgaonkar JB; Mathew MK
Biophys J; 2016 Apr; 110(8):1766-1776. PubMed ID: 27119637
[TBL] [Abstract][Full Text] [Related]
2. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
Hara H; Sakaguchi S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
[TBL] [Abstract][Full Text] [Related]
3. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.
Yang W; Cook J; Rassbach B; Lemus A; DeArmond SJ; Mastrianni JA
J Neurosci; 2009 Aug; 29(32):10072-80. PubMed ID: 19675240
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
5. Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients.
Bahadi R; Farrelly PV; Kenna BL; Kourie JI; Tagliavini F; Forloni G; Salmona M
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C862-72. PubMed ID: 12814912
[TBL] [Abstract][Full Text] [Related]
6. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Mutations within the Disordered Palindromic Region of the Prion Protein Induce Structure Therein and Accelerate the Formation of Misfolded Oligomers.
Sabareesan AT; Udgaonkar JB
J Mol Biol; 2016 Oct; 428(20):3935-3947. PubMed ID: 27545411
[TBL] [Abstract][Full Text] [Related]
8. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
Hara H; Sakaguchi S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
[TBL] [Abstract][Full Text] [Related]
9. Different effects of lipid on conformational conversion of chicken and murine prion proteins.
Wang LJ; Gu XD; Yu GH; Shen L; Ji HF
Vet Microbiol; 2018 Oct; 224():1-7. PubMed ID: 30269782
[TBL] [Abstract][Full Text] [Related]
10. Experimental Models of Inherited PrP Prion Diseases.
Watts JC; Prusiner SB
Cold Spring Harb Perspect Med; 2017 Nov; 7(11):. PubMed ID: 28096244
[TBL] [Abstract][Full Text] [Related]
11. Altered Domain Structure of the Prion Protein Caused by Cu
McDonald AJ; Leon DR; Markham KA; Wu B; Heckendorf CF; Schilling K; Showalter HD; Andrews PC; McComb ME; Pushie MJ; Costello CE; Millhauser GL; Harris DA
Structure; 2019 Jun; 27(6):907-922.e5. PubMed ID: 30956132
[TBL] [Abstract][Full Text] [Related]
12. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
[TBL] [Abstract][Full Text] [Related]
13. Identification and Structural Characterization of the Precursor Conformation of the Prion Protein which Directly Initiates Misfolding and Oligomerization.
Moulick R; Udgaonkar JB
J Mol Biol; 2017 Mar; 429(6):886-899. PubMed ID: 28147229
[TBL] [Abstract][Full Text] [Related]
14. Nascent β Structure in the Elongated Hydrophobic Region of a Gerstmann-Sträussler-Scheinker PrP Allele.
Fu ZL; Holmes PC; Westaway D; Sykes BD
J Mol Biol; 2019 Jun; 431(14):2599-2611. PubMed ID: 31034890
[TBL] [Abstract][Full Text] [Related]
15. Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.
Pirisinu L; Di Bari MA; D'Agostino C; Marcon S; Riccardi G; Poleggi A; Cohen ML; Appleby BS; Gambetti P; Ghetti B; Agrimi U; Nonno R
Sci Rep; 2016 Feb; 6():20443. PubMed ID: 26841849
[TBL] [Abstract][Full Text] [Related]
16. IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.
Gu H; Kirchhein Y; Zhu T; Zhao G; Peng H; Du E; Liu J; Mastrianni JA; Farlow MR; Dodel R; Du Y
Mol Neurobiol; 2019 Apr; 56(4):2353-2361. PubMed ID: 30027340
[TBL] [Abstract][Full Text] [Related]
17.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
18. Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease.
Qin K; Zhao L; Solanki A; Busch C; Mastrianni J
J Gen Virol; 2019 Jun; 100(6):1027-1037. PubMed ID: 31045489
[TBL] [Abstract][Full Text] [Related]
19. Channel Activities of the Full-Length Prion and Truncated Proteins.
Wu J; Wang X; Lakkaraju A; Sternke-Hoffmann R; Qureshi BM; Aguzzi A; Luo J
ACS Chem Neurosci; 2024 Jan; 15(1):98-107. PubMed ID: 38096481
[TBL] [Abstract][Full Text] [Related]
20. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]